Anika Therapeutics, Inc. (ANIK)
13.40
-0.41
(-2.97%)
USD |
NASDAQ |
Nov 13, 16:00
13.34
-0.06
(-0.41%)
After-Hours: 19:59
Anika Therapeutics EPS Diluted (Quarterly) : -0.0232 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0232 |
| June 30, 2026 | 0.2412 |
| March 31, 2026 | -0.3737 |
| December 31, 2025 | 0.0199 |
| September 30, 2025 | -0.1615 |
| June 30, 2025 | -0.2764 |
| March 31, 2025 | -0.3408 |
| December 31, 2024 | -1.50 |
| September 30, 2024 | -2.026 |
| June 30, 2024 | -0.0059 |
| March 31, 2024 | -0.3071 |
| December 31, 2023 | -4.30 |
| September 30, 2023 | -0.4493 |
| June 30, 2023 | -0.1866 |
| March 31, 2023 | -0.7063 |
| December 31, 2022 | -0.3352 |
| September 30, 2022 | -0.2859 |
| June 30, 2022 | -0.1953 |
| March 31, 2022 | -0.2028 |
| December 31, 2021 | -0.4012 |
| September 30, 2021 | 0.0381 |
| June 30, 2021 | 0.4465 |
| March 31, 2021 | 0.1966 |
| December 31, 2020 | -1.097 |
| September 30, 2020 | -0.4513 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.5429 |
| March 31, 2020 | 0.4036 |
| December 31, 2019 | 0.2771 |
| September 30, 2019 | 0.6395 |
| June 30, 2019 | 0.6697 |
| March 31, 2019 | 0.3149 |
| December 31, 2018 | 0.5397 |
| September 30, 2018 | 0.53 |
| June 30, 2018 | 0.68 |
| March 31, 2018 | -0.46 |
| December 31, 2017 | 0.53 |
| September 30, 2017 | 0.46 |
| June 30, 2017 | 0.76 |
| March 31, 2017 | 0.37 |
| December 31, 2016 | 0.54 |
| September 30, 2016 | 0.59 |
| June 30, 2016 | 0.57 |
| March 31, 2016 | 0.45 |
| December 31, 2015 | 0.72 |
| September 30, 2015 | 0.55 |
| June 30, 2015 | 0.51 |
| March 31, 2015 | 0.23 |
| December 31, 2014 | 0.51 |
| September 30, 2014 | 0.40 |
| June 30, 2014 | 0.60 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.2687 |
| MiMedx Group, Inc. | -0.0595 |
| T2 Biosystems, Inc. | -- |
| ABVC BioPharma, Inc. | 0.0431 |
| Intuitive Surgical, Inc. | 1.487 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.311M |
| Revenue (Quarterly) | 30.59M |
| Total Expenses (Quarterly) | 30.90M |
| Enterprise Value | 160.67M |
| Gross Profit Margin (Quarterly) | 61.57% |
| Profit Margin (Quarterly) | -1.02% |
| Earnings Yield | -1.01% |
| Normalized Earnings Yield | -1.013 |